Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
21 October 2014Website:
http://avanos.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
pre-market | 35 min agoDividend
Analysts recommendations
Institutional Ownership
AVNS Latest News
ALPHARETTA, Ga. , July 1, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Indrani Franchini has been appointed as a new independent member of the Avanos board of directors.
Avanos Medical, Inc. (NYSE:AVNS) Q1 2024 Earnings Conference Call will be held on May 2, 2024 at 9:00 AM ET. Present at the conference call will be Scott Galovan, Joe Woody, and Michael Greiner from the company. Also participating in the call are Kristen Stewart and Daniel Stauder from CL King and JMP Securities, respectively. Good morning everyone and welcome to the Avanos First Quarter 2024 Earnings Conference. All lines are currently on listen-only mode.
Avanos' first-quarter results demonstrate a significant increase in profits and steady growth in revenue across its segments.
Avanos Medical (AVNS) reported earnings of $0.22 per share from ongoing operations for the quarter, surpassing the Zacks Consensus Estimate of $0.21 per share. This is an improvement from earnings of $0.13 per share in the same quarter last year.
Avanos Medical (AVNS) reported earnings of $0.19 per share for the quarter, falling short of the Zacks Consensus Estimate of $0.21 per share. This is lower than the earnings of $0.27 per share reported in the same quarter last year.
Avanos Medical, Inc. (NYSE: AVNS) will be hosting a webcast of its conference call to discuss financial results and business highlights for the first quarter of 2024 on Thursday, May 2 at 9 a.m. in ALPHARETTA, Ga.
Avanos' (AVNS) strong product line and focus on R&D raise optimism about the stock.
Despite strength in Avanos' (AVNS) Digestive Health segment, its overall fourth-quarter results reflect soft performances.
ALPHARETTA, Ga. , Feb. 13, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2023 on Tuesday, Feb. 20 at 9 a.m.
ALPHARETTA, Ga. , Jan. 2, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 42nd Annual J.P.
- 1(current)
What type of business is Avanos Medical?
Avanos Medical, Inc. offers a wide range of products focused on respiratory and digestive health; pain management solutions; as well as minimally invasive interventional methods for pain treatment, closed suction systems for airways, and enteral feeding tubes. The company also offers Game Ready products for pain relief and rehabilitation of patients recovering from orthopedic surgeries or sports injuries; GRPro 2.1 cold and compression therapy system; Med4Elite, a multimodal therapy block; ATX wraps; and various accessories for products. Additionally, it sells its products under the brands ON-Q, COOLIEF, MICROCUFF, MIC-KEY, HOMEPUMP, CORTRAK, and GAME READY. Avanos Medical, Inc. was registered in 2014 and is headquartered in Alpharetta, Georgia.
What sector is Avanos Medical in?
Avanos Medical is in the Healthcare sector
What industry is Avanos Medical in?
Avanos Medical is in the Medical Devices industry
What country is Avanos Medical from?
Avanos Medical is headquartered in United States
When did Avanos Medical go public?
Avanos Medical initial public offering (IPO) was on 21 October 2014
What is Avanos Medical website?
https://avanos.com
Is Avanos Medical in the S&P 500?
No, Avanos Medical is not included in the S&P 500 index
Is Avanos Medical in the NASDAQ 100?
No, Avanos Medical is not included in the NASDAQ 100 index
Is Avanos Medical in the Dow Jones?
No, Avanos Medical is not included in the Dow Jones index
When does Avanos Medical report earnings?
The next expected earnings date for Avanos Medical is 09 August 2024